Incidence and preventability of adverse drug events in nursing homes

American Journal of Medicine

Volumn 109, Issue 2, 2000, Pages 87-94

  Gurwitz, Jerry H ^a   Field, Terry S ^a   Avorn, Jerry ^b,c   McCormick, Danny ^a   Jain, Shailavi ^a   Eckler, Marie ^a   Benser, Marcia ^a   Edmondson, Amy C ^c   Bates, David W ^b,c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIGOUT AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ANTILIPEMIC AGENT; ANTINEOPLASTIC AGENT; ANTIPARKINSON AGENT; CARDIOVASCULAR AGENT; DIURETIC AGENT; EYE DROPS; GASTROINTESTINAL AGENT; HYPNOTIC SEDATIVE AGENT; MUSCLE RELAXANT AGENT; NEUROLEPTIC AGENT; NOOTROPIC AGENT; OPIATE; STEROID; TOPICAL AGENT;

ADULT; AGED; ARTICLE; BLEEDING; DELIRIUM; DRUG INDUCED DISEASE; DRUG SURVEILLANCE PROGRAM; FALLING; FEMALE; FRACTURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NURSING HOME; PRIORITY JOURNAL; SEDATION; URTICARIA;

ACCIDENTAL FALLS; AGED; ANTICOAGULANTS; BLOOD TRANSFUSION; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CONSCIOUSNESS; DELIRIUM; DRUG MONITORING; EXANTHEMA; FRACTURES, BONE; HEMORRHAGE; HOSPITALIZATION; HUMANS; INCIDENCE; LONG-TERM CARE; MASSACHUSETTS; MEDICAL RECORDS; NURSING HOMES; PHARMACEUTICAL PREPARATIONS; PRESCRIPTIONS, DRUG; PREVENTIVE MEDICINE; PSYCHOTROPIC DRUGS; SEVERITY OF ILLNESS INDEX; URTICARIA;

EID: 0034253924     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(00)00451-4     Document Type: Article

References (37)

1. Strahan GW. An Overview of Nursing Homes and Their Current Residents: Data from the 1995 National Nursing Homes Survey. Advance Data from Vital and Health Statistics, No. 280. Hyattsville, Md: National Center for Health Statistics, 1997.
2. Bernabei R, Gambassi G, Lapane K, et al. Characteristics of the SAGE database: a new resource for research on outcomes in long-term care. J Gerontol Series A, Biological Sciences, Medical Sciences. 1999;54:M25-M33.
3. Shorr R.I., Fought R.L., Ray W.A. Changes in antipyschotic drug use in nursing homes during implementation of the OBRA-87 regulations. JAMA. 271:1994;358-362.
4. Beers M., Avorn J., Soumerai S.B., et al. Psychoactive medication use in intermediate-care facility residents. JAMA. 260:1988;3016-3020.
5. Pickering T.D., Gurwitz J.H., Zaleznick D., et al. The appropriateness of oral fluoroquinolone prescribing in the long-term care setting. J Am Geriatr Soc. 42:1994;28-32.
6. Gurwitz J.H., Noonan J.P., Soumerai S.B. Reducing the use of H2-receptor antagonists in the long-term care setting. J Am Geriatr Soc. 40:1992;359-364.
7. Ray W.A., Federspiel C.F., Schaffner W. A study of antipsychotic drug use in nursing homes epidemiologic evidence suggesting misuse . Am J Public Health. 70:1980;485-491.
8. Svarstad B.L., Mount J.K. Nursing home resources and tranquilizer use among the institutionalized elderly. J Am Geriatr Soc. 39:1991;869-875.
9. Beers M.H., Ouslander J.G., Fingold S.F., et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med. 117:1992;684-689.
10. Gerety M.B., Cornell J.E., Plichta D.T., Eimer M. Adverse events related to drugs and drug withdrawal in nursing home residents. J Am Geriatr Soc. 41:1993;1326-1332.
11. Gurwitz J.H., Sanchez-Cross M.T., Eckler M.A., Matulis J. The epidemiology of adverse and unexpected events in the long-term care setting. J Am Geriatr Soc. 42:1994;33-38.
12. Bates D.W., Cullen D.J., Laird N., et al. Incidence of adverse drug events and potential adverse drug events implications for prevention . JAMA. 274:1995;29-34.
13. Bates D.W., Boyle D.L., Vander Vliet M.B., et al. Relationship between medication errors and adverse drug events. J Gen Intern Med. 10:1995;199-205.
14. Bates DW, Leape LL, Cullen DJ, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA. 1998;280:1311-1216.
15. Leape L.L., Cullen D.J., Clapp M.D., et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 282:1999;267-270.
16. Beers M.H., Ouslander J.G., Rollingher I., et al. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 151:1991;1825-1832.
17. Beers M.H. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med. 157:1997;1531-1536.
18. Gurwitz J.H. Suboptimal medication use in the elderly. The tip of the iceberg. JAMA. 272:1994;316-317.
19. Folli HL, Poole RI, Benitz WE, Russo JC. Medication error prevention by clinical pharmacists in two children's hospitals. Pediatrics. 1987;79:781-722.
20. Dubois R.W., Brook R.H. Preventable deaths who, how often, and why . Ann Intern Med. 190:1998;582-589.
21. Katz S., Ford A.B., Moskowitz R.W., et al. Studies of illness in the aged the index of ADL. A standardized measure of biological and psychosocial function . JAMA. 185:1963;914-919.
22. Skilled nursing facility standards for certification and participation in Medicare and Medicaid programs. Fed Regist. 39:1974;2238.
23. Rosner B. Fundamentals of Biostatistics 3rd ed. Boston, Mass: PWS-Kent; 1990.
24. Phillips DP, Christenfeld, N, Glynn LM. Increase in U.S. medication-error deaths between 1983 and 1993. Lancet. 1998;351:643-644, 1983.
25. Rango N. Nursing home care in the United States. N Engl J Med. 307:1982;883-889.
26. Elon R., Paulson L.G. The impact of OBRA on medical practice within nursing facilities. J Am Geriatr Soc. 40:1992;958-963.
27. Ray W.A., Taylor J.A., Meador K.G., et al. A randomized trial of a consultation service to reduce falls in nursing homes. JAMA. 278:1997;557-562.
28. Avorn J., Soumerai S.B., Everitt D.E., et al. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med. 327:1992;168-173.
29. Ray W.A., Taylor J.A., Meador K.G., et al. Reducing antipsychotic drug use in nursing homes. A controlled trial of provider education. Arch Intern Med. 153:1993;713-721.
30. Gurwitz J.H., Monette J., Rochon P.A., et al. Atrial fibrillation and stroke prevention with warfarin in the long-term care setting. Arch Intern Med. 157:1997;978-984.
31. Dey AN. Characteristics of Elderly Nursing Home Residents: Data from the 1995 National Nursing Home Survey. Advance Data from Vital and Health Statistics, No. 289. Hyattsville, Md: National Center for Health Statistics; 1997.
32. Berwick D.M. Continuous improvement as an ideal in health care. N Engl J Med. 320:1989;53-56.
33. Leape L.L. Error in medicine. JAMA. 272:1994;1851-1857.
34. Leape L.L., Bates D.W., Cullen D.J., et al. Systems analysis of adverse drug events. JAMA. 274:1995;35-43.
35. Horton R. The uses of error. Lancet. 353:1999;422-423.
36. Bates D.W., Leape L.L., Cullen D.J., et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA. 280:1998;1311-1316.
37. Kohn LT, Corrigan JM, Donaldson MS, eds. To Err is Human: Building a Safer Health System. Washington, DC: National Academy Press; 1999.